Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria

FEMS Immunology and Medical Microbiology

Volumn 42, Issue 2, 2004, Pages 173-180

  Cross, Martin L ^a   Ganner, Anja ^a   Teilab, Diaa ^a   Fray, Linley M ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Cytokine; Escherichia coli; IL 10; IL 12; Lactobacillus; Probiotic

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; PROBIOTIC AGENT; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL ACTIVATION; CELL STIMULATION; COCULTURE; COLIFORM BACTERIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; LACTOBACILLUS CASEI; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TARGET CELL;

ANIMALS; CELL LINE; CYTOKINES; ESCHERICHIA COLI; INTERLEUKIN-10; INTERLEUKIN-12; LACTOBACILLUS CASEI; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MONOCYTES; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444326542     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.04.001     Document Type: Article

References (38)

1. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharmaceut. Design. 8:2002;99-110
2. Cross M.L. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. Med. Microbiol. 34:2002;245-253
3. Cross M.L. Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin. Appl. Immunol. Rev. 3:2002;115-125
4. Ibnou-Zekri N., Blum S., Schiffrin E.J., Von Der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal lactobacillus strains that display similar properties in vitro. Infect. Immunol. 71:2003;428-436
5. Gill H.S., Rutherfurd K.J. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br. J. Nutr. 86:2001;285-289
6. Donnet-Hughes A., Rochat F., Serrant P., Aeschlimann J.M., Schiffrin E.J. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci. 82:1999;863-869
7. Kato I., Tanaka K., Yokokura T. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int. J. Immunopharmacol. 21:1999;121-131
8. Hori T., Kiyoshima J., Yasui H. Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice. Biosci. Biotechnol. Biochem. 67:2003;420-422
9. Hori T., Kiyoshima J., Shida K., Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab Immunol. 9:2002;105-108
10. Takagi A., Matsuzaki T., Sato M., Nomoto K., Morotomi M., Yokokura T. Inhibitory effect of oral administration of Lactobacillus casei on 3 methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol. 188:1999;111-116
11. Kruis W., Schutz E., Fric P., Fixa B., Judmaier G., Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol. Ther. 11:1997;853-858
12. Vancikova Z., Lodinova-Zadnikova R., Radl J., Tlaskalova-Hogenova H. The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli. Folia Microbiol. 48:2003;281-287
13. Hockertz S. Immunomodulating effect of killed, apathogenic Escherichia coli, strain Nissle 1917, on the macrophage system. Arzneimittelforschung. 41:1991;1108-1112
14. Hockertz S. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917. Arzneimittelforschung. 47:1997;793-796
15. Lammers K.M., Helwig U., Swennen E., Rizzello F., Venturi A., Caramelli E., Kamm M.A., Brigidi P., Gionchetti P., Campieri M. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J. Gastroenterol. 97:2002;1182-1186
16. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 354(9179):1999;635-639
17. Malchow H.A. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastroenterol. 25:1997;653-658
18. Heumann D., Barras C., Severin A., Glauser M.P., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:1994;2715-2721
19. Lammers K.M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., Matteuzzi D., Campieri M. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 38:2003;165-172
20. Cross M.L., Stevenson L.M., Gill H.S. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria. Int. Immunopharmacol. 1:2001;891-901
21. Miettinen M., Lehtonen A., Julkunen I., Matikainen S. Lactobacilli and streptococci activate NF-kB and STAT signaling pathways in human macrophages. J. Immunol. 164:2000;3733-3740
22. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:2002;171-178
23. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., Kurisaki J. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem. 66:2002;1963-1966
24. Paludan S.R. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J. Leuk. Biol. 67:2000;18-25
25. Marin M.L., Tejada-Simon M.V., Lee J.H., Murtha J., Ustunol Z., Pestka J.J. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J. Food Prot. 61:1998;859-864
26. Miettinen M., Matikeinen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18 and gamma-interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66:1999;6058-6062
27. Shida K., Makino K., Morishita A., Takamizawa K., Hachimura S., Ametani A., Sato T., Kumagai Y., Habu S., Kaminogawa S. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allerg. Immunol. 115:1998;278-287
28. Cross M.L., Mortensen R., Kudsk J., Gill H.S. Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med. Microbiol. Immunol. 191:2002;49-53
29. Miettinen M., Vuopio-Varkila J., Varkila K. Production of human tumour necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:1996;5403-5405
30. Hessle C., Andersson B., Wold A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68:2000;3581-3586
31. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Sci. 81:1998;48-53
32. de Waard R., Garssen J., Bokken G.C., Vos J.G. Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol. 73:2002;93-100
33. + T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab Immunol. 8:2001;695-701
34. Chomarat P., Rissoan M.C., Banchereau J., Miossec P. Interferon gamma inhibits interleukin10 production by monocytes. J. Exp. Med. 177:1993;523-527
35. Haller D., Bode C., Hammes W.P., Pfeifer A.M., Schiffrin E.J., Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 47:2000;79-87
36. He F., Morita H., Ouwehand A.C., Hosoda M., Hiramatsu M., Kurisaki J., Isolauri E., Benno Y., Salminen S. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol. 46:2002;781-785
37. de Waard R., Claassen E., Bokken G.C., Buiting B., Garssen J., Vos J.G. Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion. Clin. Diagn. Lab Immunol. 10:2003;59-65
38. Vidal K., Donnet-Hughes A., Granato D. Lipoteichoic acids from Lactobacillus johnsonii Strain La1 and Lactobacillus acidophilus Strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun. 70:2002;2057-2064